- Launching its Chinese Daily Video News Broadcast from NYSE on cryptocurrency news in 1Q2018
- CIIX sets FY2018 goals of greater than 100% sales increase, reduced costs, and profitability
- Consilium Global Research projects CIIX to reach revenues of $14.8 million by FY2020 at a compounded annual growth rate (CAGR) of nearly 100%
- CIIX reports FY2017 YOY operating sales gain of 76%
ChineseInvestors.com, Inc. (OTCQB: CIIX) is a diverse company with goals set by Warren Wang, company founder and CEO, of a 100% gain in sales in FY2018 after achieving a 76% YOY increase in operating revenues in FY2017. The goal in FY2018 is not only the large sales gain, but a reduction in costs and profitability.
CIIX is targeting its goal of becoming the primary medical cannabis Chinese community oriented publicly-traded company. It has diverse offerings to the global Chinese-speaking population. These include financial education and market analysis, in addition to R&D and distribution of legalized, hemp-based cannabidiol (CBD). It now also offers Chinese Daily Video News Broadcast on cryptocurrencies and blockchain news from the NYSE, along with its line of CBD-infused skin care products.
At the same time, CIIX is generating subscription revenue and advertising sales. It also offers public relations and investor relations consulting services to Chinese companies.
Recently, it expanded its board by three individuals who have extensive financial and industry experience: Patrick Leung, Keevin Gillespie and Delray Wannemacher. The goal, according to CEO Wang, is to add to the company’s board individuals who can help grow the company’s Consumer Retail and Financial Services/Media divisions.
For more information, visit the company’s website at www.ChineseInvestors.com
Let us hear your thoughts: ChineseInvestors.com, Inc. Message Board
